Clinical experience of successful treatment for radiation-induced breast angiosarcomas

1. Torres K.E., Ravi V., Kin K., et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013; 20(4):1267–74. doi: 10.1245/s10434-012-2755-y.
2. Stewart F.W., Treves N. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948; 1(1): 64–81. doi: 10.1002/1097-0142(194805)1:1<64::aid-cncr2820010105>3.0.co;2-w
3. Hamels J., Blondiau P., Mirgaux M. Cutaneous angiosarcoma arising in a mastectomy scar after therapeutic irradiation. Bull Cancer .1981; 68(4): 353–6. PMID: 6274455
4. Davies J.D., Rees G.J., Mera S.L. Angiosarcoma in irradiated post-mastectomy chest wall. Histopathology. 1983; 7(6): 947–56. doi: 10.1111/j.1365-2559.1983.tb02309.x
5. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347(16): 1227–32. DOI: 10.1056/NEJMoa020989
6. Yap J., Chuba P.J., Thomas R., Aref A., Lucas D., Severson R.K., et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002; 52(2): 1231–7. doi: 10.1016/S0360-3016(01)02799-7
7. Wang X.Y., Jakowski J., Tawfik O.W., Thomas P.A., Fan F. Angiosarcoma of the breast: a clinicopathologic analysis of cases from the last 10 years. Ann Diagn Pathol, 2009; 13(3): 147–50. doi: 10.1016/j.anndiagpath.2009.02.001.
8. Marchal C., Weber B., de Lafontan B., et al. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys. 1999; 44(1): 113–19. doi: https://doi.org/10.1016/S0360-3016(98)00537-9
9. Lim S.Z., Ong K.W., Tan B.K., et al. Sarcoma of the breast: an update on a rare entity. J Clin Pathol. 2016; 69(5): 373–81. doi: 10.1136/jclinpath-2015-203545.
10. Chesebro A.L., Chikarmane S.A., Gombos E.C., Giardino A.A. Radiationassociated angiosarcoma of the breast: what the radiologist needs to know. AJR Am J Roentgenol. 2016; 207(1): 217–25. doi: 10.2214/AJR.15.15888
11. Cahan W.G., Woodard H.Q., Higinbotham N.L., Stewart F.W., Coley B.L. Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer.1998; 82(1): 8–34. doi: 10.1002/(sici)1097-0142(19980101)82:1<8::aid-cncr3>3.0.co;2-w
12. Arlen M., Higinbotham N.L., Huvos A.G., Marcove R.C., Miller T., Shah I.C. Radiation-induced sarcoma of bone. Cancer. 1971; 28(5): 1087–99. doi: 10.1002/1097-0142(1971)28:5<1087::aid-cncr2820280502>3.0.co;2-f
13. Morgan E.A., Kozono D.E., Wang Q., Mery C.M., Butrynski J.E., Baldini E.H., et al. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Onc. 2012;19(12): 3801–8. doi: 10.1245/s10434-012-2563-4.
14. D’Angelo S.P., Antonescu C.R., Kuk D., Qin L., Moraco N., Carvajal R.C., et al. Highrisk features in radiation-associated breast angiosarcomas. Br J Cancer. 2013; 109(9): 2340–6. doi: 10.1038/bjc.2013.590
15. Abbott R., Palmieri C. Angiosarcoma of the breast following surgery and radiotherapy for breast cancer. Nat Clin Pract Oncol. 2008; 5(12): 727–36. doi: 10.1038/ncponc1242.
16. Kelly NP, Siziopikou K. A 68-year-old woman with bluish discoloration of the skin of the breast. Arch Pathol Lab Med. 2002; 126(8): 989–90. doi: 10.1043/0003-9985(2002)126<0989:PQCAYO>2.0.CO;2
17. Monroe A.T., Feigenberg S.J., Mendenhall N.P. Angiosarcoma after breastconserving therapy. Cancer. 2003; 97(8): 1832–40. doi: 10.1002/cncr.11277
18. Seinen J.M., Styring E., Verstappen V., Vult von Steyern F., Rydholm A., Suurmeijer A.J., et al. Radiation-associated angiosarcoma after breast cancer: high recurrence rate and poor survival despite surgical treatment with R0 resection. Ann Surg Oncol. 2012; 19(8): 2700–6. doi:10.1245/s10434-012-2310-x.
19. Depla A.L., Scharloo-Karels C.H., de Jong M.A., et al. Treatment and prognostic factors of radiation associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J Cancer. 2014; 50(10): 1779–88. doi: 10.1016/j.ejca.2014.03.002.
20. Sinnamon A.J., Neuwirth M.G., McMillan M.T., Ecker B.L., Bartlett E.K., Zhang P.J., Kelz R.R., Fraker D.L., Roses R.E., Karakousis G.C. A prognostic model for resectable soft tissue and cutaneous angiosarcoma. J Surg Oncol. 2016; 114(5): 557–63. doi: 10.1002/jso.24352.
21. Fata F., O’Reilly E., Ilson D., et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999; 86: 2034–7. PMID: 10570428
22. Casper E.S., Waltzman R.J., Schwartz G.K., Sugarman A., Pfister D., Ilson D., Woodruff J., Leung D., Bertino J.R. Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Investig. 1998; 16(7): 442–6. doi: 10.3109/07357909809011697
23. Itakura E., Yamamoto H., Oda Y., Tsuneyoshi M. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J Surg Oncol. 2008;97 (1): 74–81. doi: 10.1002/jso.20766
24. Agulnik M., Yarber J.L., Okuno S.H., von Mehren M., Jovanovic B.D., Brockstein B.E., Evens A.M., Benjamin R.S. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013; 24(1): 257–63. doi: 10.1093/annonc/mds237.
25. Ray-Coquard I.L., Domont J., Tresch-Bruneel E., et al: Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: A randomized phase II trial. J Clin Oncol. 2015; 33(25): 2797–802. doi: 10.1200/JCO.2015.60.8505
26. Сопромадзе С.В., Соболевский В.А., Крохина О.В., Феденко А.А. Лечение сарком молочной железы. Обзор литературы. Саркомы костей, мягких тканей и опухоли кожи. 2018;1: 33–38.[Sopromadze S.V., Sobolevsky V.A., Krochina O.V., Fedenko A.A. Treatment of breast sarcomas. Review of literature. Sarkomy kostej, mjagkih tkanej i opuholi kozhi. 2018;1: 33–38. (in Russ.)]. eLIBRARY ID: 35352033

Received 01.11.2019

Accepted 29.11.2019